Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest

PURPOSE: We aimed to identify the risk factors of critical bleeding and investigate the safety of recombinant activated factor VII (rFVIIa) in aortic surgery under hypothermic circulatory arrest (HCA). PATIENTS AND METHODS: The present single-center retrospective study compared the baseline characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ise, Hayato, Ushioda, Ryohei, Kanda, Hirotsugu, Kimura, Fumiaki, Saijo, Yasuaki, Akhyari, Payam, Lichtenberg, Artur, Kamiya, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994620/
https://www.ncbi.nlm.nih.gov/pubmed/35411145
http://dx.doi.org/10.2147/TCRM.S352609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994620/
https://www.ncbi.nlm.nih.gov/pubmed/35411145
http://dx.doi.org/10.2147/TCRM.S352609

Ejemplares similares